The company will evaluate the Hepzato kit as a combination therapy with the standard of care in patients with liver-dominant ...

Bevacizumab biosimilars have the potential to expand access and reduce costs without compromising patient outcomes in ...

Progression-free survival was improved among patients who received nivolumab and ipilimumab, and toxicity was generally greater among patients who received chemotherapy.

Cadonilimab plus chemotherapy, with or without bevacizumab, could be a safe and effective treatment option, according to researchers.

Atezolizumab (Tecentriq) + bevacizumab (Avastin) + chemotherapy for ovarian cancer TS ID 10701 Technology appraisal guidance TBC Atezolizumab as neoadjuvant (with chemotherapy) and adjuvant (as ...

Researchers have used a new gold-based drug to slow tumor growth in animals by 82% and target cancers more selectively than standard chemotherapy drugs, according to a new study. A new gold-based ...

This page includes links to articles highlighting the top lung cancer research published on Cancer Therapy Advisor in 2024.

Citadel ended September with 91% fewer Palantir shares, despite the stock's eye-popping gains, after selling about 5.2 ...

“This approval demonstrates the benefits of adding a biological agent, Zaltrap, to a commonly used chemotherapy drug regimen ... with Roche Holding AG’s Avastin (bevacizumab) and Bristol ...

Chemotherapy is a treatment used to kill cancer cells ... testing the superiority of adding cetuximab (anti-EGFR) over bevacizumab (anti-VEGF) to modified FOLFOXIRI (5-FU, leucovorin, oxaliplatin ...